Audiologic monitoring for ototoxicity.
In summary, the clinician has a variety of protocols available for monitoring ototoxicity. Depending on the patient's risk factors and ability to be tested, the protocol for a given patient may vary. A flow chart reflecting some of the possible decisions and options is presented in Figure 1. Certainly, as we learn more about ototoxicity and the advantages and disadvantages of the various test methods, further refinements of patient and test selection will ensue. Ototoxicity is a rapidly expanding and interesting area. Hopefully, the care of patients receiving ototoxic medications will continue to improve and will ultimately prevent, or at least ameliorate, ototoxic hearing loss.
Campbell
K C
KC
Southern Illinois University School of Medicine, Springfield.
Durrant
J
J
D001298:Audiology / Q000379:methods; D001309:Auditory Threshold / Q000502:physiology; D002648:Child; D003051:Cochlea / Q000187:drug effects; D006311:Hearing Disorders / Q000139:chemically induced* / Q000175:diagnosis*; D006320:Hearing Tests; D006801:Humans; D007223:Infant; D017084:Otoacoustic Emissions, Spontaneous / Q000502:physiology